GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the recombinant human alpha I tryptase mutant D216G in complex with leupeptin

Analyse Crystal structure of the recombinant human alpha I tryptase mutant D216G in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2F9P
Type
protein
Length
983 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tryptase alpha-1; Leupeptin
EC
3.4.21.59
Ligands
ACE, NAG, FUC
Pockets
9 · best druggability 0.66

Structure

x-ray diffraction · 3 distinct chains · 9% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CTryptase alpha-1 (EC 3.4.21.59)protein2439% helix, 36% strand—
E, F, G, HLeupeptinprotein30% helix, 33% strand—
DTryptase alpha-1 (EC 3.4.21.59)protein2429% helix, 36% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 4 copies · chains A, E, B, F, C, G, H
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains D, B
  • FUC · alpha-L-fucopyranose · sugar
  • BU3 · (R,R)-2,3-butanediol · additive · 4 copies · chains A, D, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15250.660.7783empty
22690.520.7547empty
3700.510.8523empty
41230.430.7616empty
5730.350.7617empty

Interfaces

12 interfaces between chains.

  • B–C · 1305 Ų buried · 14 hydrogen bonds · protein-protein
  • A–D · 1288 Ų buried · 16 hydrogen bonds · protein-protein
  • C–D · 623 Ų buried · 3 hydrogen bonds · protein-protein
  • A–B · 590 Ų buried · 6 hydrogen bonds · protein-protein
  • B–F · 351 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 disulfide, 4 covalent, 4 modified, 2 glycan (disulfide, covalent ligand, nonstandard, N-glycosylation).

Compared structures

  • 2F9P · Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.